Lidia Mak

710 total citations
11 papers, 589 citations indexed

About

Lidia Mak is a scholar working on Biomaterials, Molecular Biology and Oncology. According to data from OpenAlex, Lidia Mak has authored 11 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Biomaterials, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Lidia Mak's work include Nanoparticle-Based Drug Delivery (7 papers), RNA Interference and Gene Delivery (5 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Lidia Mak is often cited by papers focused on Nanoparticle-Based Drug Delivery (7 papers), RNA Interference and Gene Delivery (5 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Lidia Mak collaborates with scholars based in Israel and United States. Lidia Mak's co-authors include Alberto Gabizón, Dina Tzemach, Hilary Shmeeda, Yasmine Amitay, Jenny Gorin, Aviva T. Horowitz, Dinah Tzemach, Alberto Gabizon, Samuel Zalipsky and Saran Kumar and has published in prestigious journals such as Journal of Controlled Release, Pharmaceutical Research and Molecular Cancer Therapeutics.

In The Last Decade

Lidia Mak

11 papers receiving 582 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lidia Mak Israel	9	395	278	232	114	68	11	589
Kiran R. Chaudhari India	7	255 0.6×	253 0.9×	179 0.8×	129 1.1×	87 1.3×	8	529
Shravan Kumar Sriraman United States	8	289 0.7×	321 1.2×	234 1.0×	94 0.8×	30 0.4×	10	602
Henrike Caysa Germany	13	225 0.6×	211 0.8×	237 1.0×	115 1.0×	79 1.2×	15	662
P. Vasey United Kingdom	4	359 0.9×	274 1.0×	200 0.9×	126 1.1×	54 0.8×	7	649
Ela Markovsky Israel	11	298 0.8×	268 1.0×	179 0.8×	115 1.0×	61 0.9×	15	696
Alexandra Arranja Netherlands	11	243 0.6×	185 0.7×	216 0.9×	63 0.6×	93 1.4×	21	576
Seong Ik Jeon South Korea	13	183 0.5×	206 0.7×	256 1.1×	115 1.0×	49 0.7×	26	579
Shannon C. Leonard United States	7	358 0.9×	236 0.8×	305 1.3×	156 1.4×	148 2.2×	18	631
Senat Krasnici Germany	7	255 0.6×	254 0.9×	171 0.7×	69 0.6×	23 0.3×	8	505
Ella N. Hoogenboezem United States	6	186 0.5×	265 1.0×	159 0.7×	118 1.0×	60 0.9×	9	563

Countries citing papers authored by Lidia Mak

Since Specialization

Citations

This map shows the geographic impact of Lidia Mak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lidia Mak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lidia Mak more than expected).

Fields of papers citing papers by Lidia Mak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lidia Mak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lidia Mak. The network helps show where Lidia Mak may publish in the future.

Co-authorship network of co-authors of Lidia Mak

This figure shows the co-authorship network connecting the top 25 collaborators of Lidia Mak. A scholar is included among the top collaborators of Lidia Mak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lidia Mak. Lidia Mak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Gabizón, Alberto, Patricia Ohana, Yasmine Amitay, et al.. (2021). Liposome co-encapsulation of anti-cancer agents for pharmacological optimization of nanomedicine-based combination chemotherapy. Cancer Drug Resistance. 4(2). 463–484. 11 indexed citations

Shmeeda, Hilary, Yasmine Amitay, Jenny Gorin, et al.. (2016). Coencapsulation of alendronate and doxorubicin in pegylated liposomes: a novel formulation for chemoimmunotherapy of cancer. Journal of drug targeting. 24(9). 878–889. 38 indexed citations

Amitay, Yasmine, Hilary Shmeeda, Yogita P. Patil, et al.. (2015). Pharmacologic Studies of a Prodrug of Mitomycin C in Pegylated Liposomes (Promitil®): High Stability in Plasma and Rapid Thiolytic Prodrug Activation in Tissues. Pharmaceutical Research. 33(3). 686–700. 33 indexed citations

Shmeeda, Hilary, Yasmine Amitay, Jenny Gorin, et al.. (2010). Delivery of zoledronic acid encapsulated in folate-targeted liposome results in potent in vitro cytotoxic activity on tumor cells. Journal of Controlled Release. 146(1). 76–83. 77 indexed citations

Gabizón, Alberto, Dina Tzemach, Jenny Gorin, et al.. (2009). Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models. Cancer Chemotherapy and Pharmacology. 66(1). 43–52. 99 indexed citations

Shmeeda, Hilary, Dina Tzemach, Lidia Mak, & Alberto Gabizón. (2009). Her2-targeted pegylated liposomal doxorubicin: Retention of target-specific binding and cytotoxicity after in vivo passage. Journal of Controlled Release. 136(2). 155–160. 80 indexed citations

Shmeeda, Hilary, Jenny Gorin, Lidia Mak, et al.. (2007). Intracellular delivery of liposome-encapsulated zoledronic acid via folate receptor results in significant inhibition of tumor cell growth. Molecular Cancer Therapeutics. 6. 1 indexed citations

Shmeeda, Hilary, et al.. (2006). Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors. Molecular Cancer Therapeutics. 5(4). 818–824. 109 indexed citations

Gabizón, Alberto, Aviva T. Horowitz, Dinah Tzemach, et al.. (2002). Folate receptor targeting of pegylated liposomal cisplatin enhances anti-tumor activity in mouse models without increasing toxicity. 43. 415. 2 indexed citations

10.

Gabizón, Alberto, et al.. (2002). Dose Dependency of Pharmacokinetics and Therapeutic Efficacy of Pegylated Liposomal Doxorubicin (DOXIL) in Murine Models. Journal of drug targeting. 10(7). 539–548. 128 indexed citations

11.

McNutt, N. Scott, Lidia Mak, & Y S Kim. (1981). Comparison of cell peripheries in the human colonic adenocarcinoma cell lines SW480 and SW620 grown in floating chamber culture, cover slip culture, athymic (nude) mice, and BALB/c mice.. PubMed. 44(4). 309–23. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact